PMDA drug package insert
グラッシュビスタ外用液剤0.03%5mL
PMDA Prescription drug · アッヴィ合同会社 · package insert Aug 1, 2023
Key facts
| Brand names | グラッシュビスタ外用液剤0.03%5mL |
|---|---|
| Nonproprietary names | ビマトプロスト |
| Companies | 製造販売元／アッヴィ合同会社 |
| Product type | Prescription drug |
| Therapeutic category | プロスタマイド誘導体 |
| Therapeutic category codes | 872679 |
| YJ codes | 267970AQ1020 |
| Approval numbers | 22600AMX00551000 |
| Package insert edition | 第1版 |
| Package insert date | Aug 1, 2023 |
| PMDA document key | 112130_267970AQ1020_3 |
| PMDA company code | 112130 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: